Dietary manipulation in musculoskeletal conditions

Dietary advice and intervention clearly have a place in rheumatology and allow patients to have some control over their own disease. Although there is no evidence for efficacy of 'fad' diets, 30-40% of rheumatoid patients can benefit from excluding foods individually identified during the reintroduction phase of an elimination diet. A proportion of patients who follow a vegetarian or Mediterranean-type diet will experience benefit. Patients who are either overweight or obese should participate in weight-loss programmes. Those with osteoarthritis need to concentrate on reducing fat mass while maintaining muscle mass. Arthritic patients, other than those with gout, should increase their intake of oily fish and additionally supplement with fish oil for up to 3 months to see whether they experience benefit. All arthritic patients, particularly those with inflammatory disease, should be advised to ensure a good dietary intake of antioxidants, copper and zinc. Supplementation with selenium and vitamin D may be advisable.     

Telemedicine: military applications.

Communications technology has enjoyed enormous growth in recent years and should be fully exploited by the medical community. Its application as part of disaster response was well demonstrated in the aftermath of the tragic earthquake in Soviet Armenia in 1988. Besides disaster response, telemedicine also has application for patient care, diagnostic imaging, and training and education. This capability would be particularly beneficial to the armed forces of many nations. If the communications equipment were portable, it could be well employed during peacetime, yet easily deployed to the battlefield. Therefore, armed forces should fully exploit telecommunications technology for the practice of military medicine.     

Lead encephalopathy from an imported Toby mug

Encephalopathy is an unusual manifestation of lead poisoning in an adult, the more common presentation being abdominal colic, anaemia and limb palsy. We report a case of adult lead encephalopathy and describe the use of a simple screening test for lead poisoning together with the increasing number of cases associated with imported ceramics.     

Dependent oedema and attenuation of postural vasoconstriction associated with nifedipine therapy for hypertension in diabetic patients

Summary We studied the incidence of oedema 2 weeks following initation of nifedipine therapy for hypertension in a group of 10 diabetic subjects, and also measured skin blood flow (SBF) with a laser Doppler flowmeter, before and after lowering the foot.SBF with the foot horizontal increased after nifedipine from 0.31V (arbitrary units of flow) to 0.51V (NS). The postural fall in blood flow in dependency was significantly attenuated by nifedipine from 64.4 to 24.0%.Five patients developed ankle oedema. Results were similar in a small group of non-diabetic subjects starting nifedipine.The attenuation of reflex postural vasoconstriction is therefore likely to contribute to development of the oedema associated with starting nifedipine therapy, which should be monitored carefully in diabetic patients.     

Insulin Deficiency and Increased Plasma Concentration of Intact and 32/33 Split Proinsulin in Subjects with Impaired Glucose Tolerance

In order to determine insulin status and beta cell function during the oral glucose tolerance test (OGTT), in impaired glucose tolerance (IGT), 51 such subjects and matched controls, identified during a population survey for diabetes, underwent a 75 g OGTT. Fasting, 30 min and 2 h insulin and intact proinsulin, and fasting and 2 h 32/33 split proinsulin, were measured by specific two-site immunoradiometric assays. The subjects with IGT had higher fasting (geometric mean ± SD, 5.0 ± 4.0 pmol^?1 vs 2.9 ± 1.7, p < 0.02) and 2 h intact proinsulin (23 ± 14 vs 14 ± 12, p < 0.0001), and fasting (3.2 ± 3 pmol^?1 vs 1.8 ± 1.8, p < 0.0007) and 2 h 32/33 split proinsulin (18.3 ± 19 pmol^?1 vs 6.6 ± 15, p < 0.0001). Despite higher plasma glucose concentrations, the IGT group had similar fasting insulin, lower 30 min insulin (216 ± 124 pmol^?1 vs 278 ± 130, p < 0.02), and a lower 30 min insulin/glucose ratio (23.7 ± 2.1 vs 34.8 ± 2.3, p < 0.002). The percentage of fasting proinsulin-like to total insulin-like molecules was higher in those with IGT (15.3 ± 8% vs 11.6 ± 8, p < 0.04). After 6 months, at repeat OGTT, the same subjects with IGT were classified as ‘persisters’ or ‘reverters’. The persister (24/51 47.1%), at initial OGTT, had a higher 2 h glucose level, a greater BMI and higher systolic blood pressure, but other parameters were similar to the reverters. In the reverters, when baseline variables were compared to those recorded at six month follow-up, there was a reduction in 2 h intact (23.8 ± 13 pmol^?1 vs 19.4 = 10, p < 0.02) and 32/33 split proinsulin (20.4 ± 18 pmol^?1 vs 13.8 ± 13, p < 0.006), and an increase in fasting insulin (41 ± 30 pmol^?1 vs 54 ± 35, p < 0.02), respectively, despite no change in fasting glucose. These findings show that IGT is associated with beta cell dysfunction and reduced early insulin secretion during the OGTT. In some subjects with IGT these abnormalities show improvement in the short term.